Literature DB >> 29619772

Molecular Med TRI-CON, 11-16 February 2018, San Francisco, USA.

Alison Fitches1.   

Abstract

Mesh：

Year:  2018        PMID： 29619772     DOI： 10.1007/s40291-018-0326-z

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN： 1177-1062            Impact factor:   4.074


× No keyword cloud information.
  8 in total

1.  Identification of Cancer-Associated Fibroblasts in Circulating Blood from Patients with Metastatic Breast Cancer.

Authors:  Zheng Ao; Sanket H Shah; Leah M Machlin; Ritesh Parajuli; Philip C Miller; Siddarth Rawal; Anthony J Williams; Richard J Cote; Marc E Lippman; Ram H Datar; Dorraya El-Ashry
Journal:  Cancer Res       Date:  2015-10-15       Impact factor: 12.701

2.  The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA.

Authors:  Sonya Parpart-Li; Bjarne Bartlett; Maria Popoli; Vilmos Adleff; Laura Tucker; Rebecca Steinberg; Andrew Georgiadis; Jill Phallen; Julie Brahmer; Nilo Azad; Ilene Browner; Daniel Laheru; Victor E Velculescu; Mark Sausen; Luis A Diaz
Journal:  Clin Cancer Res       Date:  2016-11-08       Impact factor: 12.531

Review 3.  The Importance of Standardization on Analyzing Circulating RNA.

Authors:  Inyoul Lee; David Baxter; Min Young Lee; Kelsey Scherler; Kai Wang
Journal:  Mol Diagn Ther       Date:  2017-06       Impact factor: 4.074

4.  Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide.

Authors:  Emmanuel S Antonarakis; Changxue Lu; Brandon Luber; Hao Wang; Yan Chen; Yezi Zhu; John L Silberstein; Maritza N Taylor; Benjamin L Maughan; Samuel R Denmeade; Kenneth J Pienta; Channing J Paller; Michael A Carducci; Mario A Eisenberger; Jun Luo
Journal:  J Clin Oncol       Date:  2017-04-06       Impact factor: 44.544

5.  Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer.

Authors:  K C Allen Chan; John K S Woo; Ann King; Benny C Y Zee; W K Jacky Lam; Stephen L Chan; Sam W I Chu; Constance Mak; Irene O L Tse; Samantha Y M Leung; Gloria Chan; Edwin P Hui; Brigette B Y Ma; Rossa W K Chiu; Sing-Fai Leung; Andrew C van Hasselt; Anthony T C Chan; Y M Dennis Lo
Journal:  N Engl J Med       Date:  2017-08-10       Impact factor: 91.245

6.  Utility of Genomic Analysis In Circulating Tumor DNA from Patients with Carcinoma of Unknown Primary.

Authors:  Shumei Kato; Nithya Krishnamurthy; Kimberly C Banks; Pradip De; Kirstin Williams; Casey Williams; Brian Leyland-Jones; Scott M Lippman; Richard B Lanman; Razelle Kurzrock
Journal:  Cancer Res       Date:  2017-06-22       Impact factor: 12.701

7.  Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer.

Authors:  R Jonas A Nilsson; Niki Karachaliou; Jordi Berenguer; Ana Gimenez-Capitan; Pepijn Schellen; Cristina Teixido; Jihane Tannous; Justine L Kuiper; Esther Drees; Magda Grabowska; Marte van Keulen; Danielle A M Heideman; Erik Thunnissen; Anne-Marie C Dingemans; Santiago Viteri; Bakhos A Tannous; Ana Drozdowskyj; Rafael Rosell; Egbert F Smit; Thomas Wurdinger
Journal:  Oncotarget       Date:  2016-01-05

8.  Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition.

Authors:  Verena Tiran; Joerg Lindenmann; Luka Brcic; Ellen Heitzer; Stefanie Stanzer; Nassim Ghaffari Tabrizi-Wizsy; Elvira Stacher; Herbert Stoeger; Helmut H Popper; Marija Balic; Nadia Dandachi
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.